Similarly, the patients with a low CD3+ TIL density and a high CD24/CD44 coexpression in tumor cells had the worst DFS, MFS, and OS, with a median of 3.9 years for both DFS and MFS (Figure 5B). This evidence concerns the gene CD44 and neoplasm.